Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial

Joël Guigay, Hervé Le Caer, François-Régis Ferrand, Lionel Geoffrois, Esma Saada-Bouzid, Jérôme Fayette, Christian Sire, Didier Cupissol, Emmanuel Blot, Pierre Guillet, Julien Pavillet, Laurence Bozec, Olivier Capitain, Frédéric Rolland, Philippe Debourdeau, Yoann Pointreau, Claire Falandry, Stéphane Lopez, Alexandre Coutte, Thierry Chatellier, Pierre Dalloz, Cécile Ortholan, Cécile Michel, Benjamin Lacas, Nadir Cheurfa, Dominique Schwob, Jean Bourhis, Cécile Mertens, Anne Aupérin

Open source

DOI: 10.1016/s2666-7568(24)00048-5
Published: 2024-06
Container: The Lancet Healthy Longevity
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2666-7568-24-00048-5,
  title = {Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial},
  author = {Joël Guigay and Hervé Le Caer and François-Régis Ferrand and Lionel Geoffrois and Esma Saada-Bouzid and Jérôme Fayette and Christian Sire and Didier Cupissol and Emmanuel Blot and Pierre Guillet and Julien Pavillet and Laurence Bozec and Olivier Capitain and Frédéric Rolland and Philippe Debourdeau and Yoann Pointreau and Claire Falandry and Stéphane Lopez and Alexandre Coutte and Thierry Chatellier and Pierre Dalloz and Cécile Ortholan and Cécile Michel and Benjamin Lacas and Nadir Cheurfa and Dominique Schwob and Jean Bourhis and Cécile Mertens and Anne Aupérin},
  year = {2024},
  journal = {The Lancet Healthy Longevity},
  doi = {10.1016/s2666-7568(24)00048-5},
  url = {https://doi.org/10.1016/s2666-7568(24)00048-5}
}

RIS

TY  - JOUR
TI  - Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial
AU  - Joël Guigay
AU  - Hervé Le Caer
AU  - François-Régis Ferrand
AU  - Lionel Geoffrois
AU  - Esma Saada-Bouzid
AU  - Jérôme Fayette
AU  - Christian Sire
AU  - Didier Cupissol
AU  - Emmanuel Blot
AU  - Pierre Guillet
AU  - Julien Pavillet
AU  - Laurence Bozec
AU  - Olivier Capitain
AU  - Frédéric Rolland
AU  - Philippe Debourdeau
AU  - Yoann Pointreau
AU  - Claire Falandry
AU  - Stéphane Lopez
AU  - Alexandre Coutte
AU  - Thierry Chatellier
AU  - Pierre Dalloz
AU  - Cécile Ortholan
AU  - Cécile Michel
AU  - Benjamin Lacas
AU  - Nadir Cheurfa
AU  - Dominique Schwob
AU  - Jean Bourhis
AU  - Cécile Mertens
AU  - Anne Aupérin
PY  - 2024
JO  - The Lancet Healthy Longevity
DO  - 10.1016/s2666-7568(24)00048-5
UR  - https://doi.org/10.1016/s2666-7568(24)00048-5
ER  -

APA

Guigay, J., Caer, H. L., Ferrand, F., Geoffrois, L., Saada-Bouzid, E., Fayette, J., Sire, C., Cupissol, D., Blot, E., Guillet, P., Pavillet, J., Bozec, L., Capitain, O., Rolland, F., Debourdeau, P., Pointreau, Y., Falandry, C., Lopez, S., Coutte, A., Chatellier, T., Dalloz, P., Ortholan, C., Michel, C., Lacas, B., Cheurfa, N., Schwob, D., Bourhis, J., Mertens, C., & Aupérin, A. (2024). Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(24)00048-5

Source records

crossref · retrieved 2026-09-26T01:38:07.302Z